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Abstract
The study aim was to explore local anesthetic properties of some tertiary and quaternary derivatives of dimethylacetamide. 
Materials and methods. The study was performed on white laboratory mice and rats of both sexes, male Agouti guinea 
pigs, and isolated sciatic nerves of lake frog. In the focus of the study there were two quaternary and eight tertiary com-
pounds of dimethylacetamide with substituted anion with some amino and carbonic acids residue. A local anesthetic 
property was predicted by computational analysis. Acute toxicity of the most promising substances was studied in mice 
through subcutaneous route. Local anesthetic activity of tertiary compounds LKhT-3-00, LKhT-4-00 and quaternary 
LKhT-12-02 was studied on models of terminal, infiltration and conduction anesthesia. The influence of substances on 
mixed nerve conduction was investigated on lake frog’s isolated sciatic nerves. 
Results and discussion. The greatest probability of the local anesthetic activity during computational analysis was es-
timated for the tertiary derivatives of dimethylacetamide LKhT-3-00 and LKhT-4-00 and for the quaternary compound 
LKhT-12-02. According to their toxicological profile, the compounds belong to moderately toxic substances (class 3). 
On the model of terminal and infiltration anesthesia, substances LKhT-3-00 and LKhT-4-00 at concentrations of 0.5-
1% rapidly cause deep and prolonged anesthesia. On the models of conduction anesthesia, the quaternary derivative of 
dimethylacetamide LKhT-12-02 has the greatest analgesic effect. The duration of the effect of the substance is over 3 
hours. All the investigated compounds block sciatic nerve conduction. The longest effect is registered for LKhT-12-02.
Conclusions. Dimethylacetamide derivatives at concentrations of 0.5-1.0% exhibit a local anesthetic activity, and are 
effective for terminal, conduction and infiltration anesthesia. Their effect is due to blockade of nerve conduction.
Keywords
local anesthesia, dimethylacetamide compounds, terminal anesthesia, conduction, computational prediction, acute tox-
icity, isolated nerve.
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Introduction
Over the past decades, revolutionary changes in clinical 
practice, the creation and widespread introduction of new 
high-tech methods of diagnosis and treatment make new 
demands for a modern drug for local anesthesia (Chiti-
lian et al. 2016, Mennito 2016). Medical manipulations, 
which used to be impossible outside the hospital, have 
now become routine for outpatient surgery and invasive 
diagnostics (Mennito 2016).
The factor of the aging population, the extremely 
spread comorbidity, increasing requirements for drug 
safety, reduced cost of both a local anesthetic drug and 
medical equipment, as well as other resource costs 
associated with its use have great importance for the 
choice of a means and method of anesthesia at the 
present time (Forman 2010). Of particular importance 
when selecting a local anesthetic is the pharmacologi-
cal characteristics, such as the rate of development of 
the effect, the depth of local anesthesia, the duration of 
action, and the speed of anesthesia recovery (Mennito 
2016, Forman 2010).
Since its discovery and appearance in clinical practice, 
lidocaine has been the most common local anesthetic drug 
(Malamed 2007), which has assumed “the gold standard 
status” in dental and ophthalmic practices, as well as in 
outpatient surgery. However, a short duration of the drug 
action, a relatively wide range of its adverse effects made 
pharmacologists and clinicians search for more optimal 
medicinal solutions in this area.
At present, research in the field of pharmacology of lo-
cal anesthetics is carried out in two main directions. The 
first, more traditional for pharmacologists, is related to 
the search for novel or chemically modified well-known 
molecules of medicinal substances. Great progress has 
been made in the stereopharmacology of bupivacaine, 
ropivacaine, etc. (Da Silva et al. 2017). However, it is 
becoming more important worldwide not just to deve-
lop novel effective molecules for a given type of local 
anesthesia, but rather to invent promising drug delivery 
systems (Riberio et al. 2017), which would allow, first, 
localizing the pharmacological effect at most, secondly, 
managing the profile of unwanted effects, and, finally, 
bringing the efficacy and safety of anesthetic relief to a 
qualitatively new level.
Recently, studies focusing on lidocaine (dimethylaceta-
mide) derivatives have intensified in Russia. In a series of 
studies, their antiarrhythmic medication (Blinov and Kos-
tin 2003; Blinov et al. 2014; Sernov et al. 2005) and the 
anti-ischemic (Kostin et al. 2003) activities were studied, 
and it was shown that the derivatives exceed their structu-
ral ancestor both by duration and by efficiency in experi-
mental animals (Blinova et al. 2015) and in vitro (Balas-
hov et al. 2005). All this served as the basis for assuming 
that this group of amino acid-substituted and quaternary 
derivatives of dimethylacetamide had a local anesthetic 
activity, which determined the relevance of this study.
Materials and methods
All the study protocols were reviewed and approved by 
the Local Ethics Committee of National Research Ogarev 
Mordovia State University (Minutes No. 10 of October 
20, 2016). 
Animals and biological materials
The experiments were performed on various laboratory 
animals and using biological material: 95 isolated sciatic 
nerves of Rana radibunda lake frog, 95 white rats of both 
sexes weighing 180–220 g, 265 SHK mice of both sexes 
weighing 18–22 g, 36 male guinea pigs (Agouti strain), 
and 18 male Soviet chinchilla rabbits. The laboratory ani-
mals were purchased in ”Stolbovaya” and “Andreevka” 
Animal Breeding Facilities. The animals were maintained 
at the vivarium of National Research Ogarev Mordovia 
State University under conventional conditions, which met 
all the requirements of The National Standard of the Rus-
sian Federation “Principles of Good Laboratory Practice”.
Substances and drugs
The object of the study was tertiary derivatives of dime-
thylacetamide with an anion substituted with an amino 
or carboxylic acid residue, synthesized at The All-Union 
Scientific Center for the Safety of Biologically Active 
Substances at the Department of Chemistry and Techno-
logy of Synthetic Medications. Also, two quaternized sys-
tems, chemically derived from dimethylacetamide, were 
used as the object of the study. One of them contained 
the nitrogen atom in the aliphatic residue of the molecule, 
which was introduced into a cyclic structure (a compound 
under the laboratory code – LKhT-12-02). The other one 
was saturated with an additional radical with a covalent 
bond (a derivative under the laboratory code – LKhT-13-
02). The physical and chemical characteristics of the ter-
tiary substances are presented in Table 1.
All the compounds were studied as substances. Their 
solutions were prepared ex tempore, using twice-distilled 
water as a solvent. In all the models, the structural an-
cestor of the derivatives – lidocaine hydrochloride (Lido-
caine Bufus by Renewal in plastic ampoules containing 
2 ml of 10% solution, exp. date 11.2017, series 02354) 
was tested as a reference drug. In the study of the acute 
toxicity in case of subcutaneous administration and of a 
local anesthetic action on the terminal corneal anesthesia 
model, tetracaine hydrochloride was used as a referen-
ce drug (Tetracaine Hydrochloride Ophthalmic Solution 
USP 0.5% in 15 ml bottles, by Bousch and Lomb Pharma-
ceuticals, USA, exp. date 05.2018, series L47643). On the 
models of conduction anesthesia, bupivacaine hydrochlo-
ride (Bupivacaine Grindex by Grindex, Latvia, 5 mg/ml 
of bupivacaine monohydrate in 4 ml ampoules, series 
15487, exp. date 12.2017) was used as a reference drug.
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Reference drug solutions for terminal anesthesia were 
prepared immediately before use at the required concen-
tration. In other models of anesthesia, the doses of the 
drugs were calculated basing on the available literature 
data concerning their acute toxicity index determined for 
subcutaneous administration. Also, based on the toxico-
logical profile data, doses were calculated for dimethy-
lacetamide derivatives. In case when toxicological studies 
and studies of local anesthetic effects were carried out in 
different specimen of animals, the dose conversion factors 
were used from (Freireich et al. 1966).
Experimental methods
The screening of activity and toxicity of the compounds 
was carried out by PASS (Prediction of Activity Spectra 
for Substances, version 9.1) computer-based method for 
predicting the biological activity of substances, based on 
analysis of training samples by Poroykov et al. (2000). 
The derivatives’ acute toxicity when administered sub-
cutaneously was investigated in accordance with interna-
tional recommendations (Gad 2007). To study the local 
anesthetic activity of dimethylacetamide derivatives, a 
terminal anesthesia models of the rabbit eye cornea (Reg-
nier 1982) and an infiltration anesthesia method in Agouti 
guinea pigs (Bulbring and Wajda 1945) were used. The 
local anesthetic activity of the derivatives on the models 
of conduction anesthesia was determined by tail-flick test 
in mice and sciatic nerve blockade model in rats (Ouchi 
et al. 2013). The local irritant effect of the compounds 
was studied by Setnicar (1966). The impact of the studied 
compounds on the impulse conduction was studied in vi-
tro experiments on frog isolated sciatic nerve specimens.
Statistical processing of the obtained results was car-
ried out using conventional statistics methods by means 
of BioStat® software for Microsoft Windows, SPSS and 
PC iMac Retina (USA).
Results and discussion
The first stage of this study involved the pharmacological 
screening in the series of tertiary derivatives of dimethy-
lacetamide and quaternized systems with a phenylaceta-
mide base for the presence of local anesthetic activity in 
their spectrum. Using the PASS system, the probability of 
presence (Pa) and absence (Pi) of pharmacological acti-
vity was evaluated (the maximum probability is 1) in the 
series of the substances. Figure 1 represents the obtain-
ed results. The computerized prediction showed that two 
Table 1. Physical and Chemical Characteristics of Tertiary and Quaternary Derivatives of Dimethylacetamide
No. Laboratory code Gross-formula of 
a derivative
Chemical name M Melting 
T, ºС
1. LKhT-3-00 С19Н31N3О5 L-Glutamate 2-Diethylamino-2
',6'-Dimethylacetamide 615.81 72–75
2. LKhT -4-00 С35Н55N5О7 N-Acetyl-L-Glutamate 2- Diethylamino-2
',6'-Dimethylacetamide 657.83 80–83
3. LKhT -5-00 С16Н27N3О3 Amino acetate 2- Diethylamino-2
',6'-Dimethylacetamide 309.41 74–76
4. LKhT -6-00 С18Н28N2О5 Succinate 2- Diethylamino-2
',6'-Dimethylacetamide 352.42 120–122
5. LKhT -2-01 С19Н31N3О4S N-acetylcysteinate 2- Diethylamino-2
',6'-Dimethylacetamide 397.53 39–42
6. LKhТ-4-01 С17Н29N3О3 2-amino propionate 2- Diethylamino-2
',6'-Dimethylacetamide 323.43 75–78
7. LKhT -5-01 С20Н36N6О3 L-arginate 2- Diethylamino-2
',6'-Dimethylacetamide 408.55 80–83
8. LKhT -6-01 С23Н33N3О3 β-Phenyl-α-amino propionate 2- Diethylamino-2
',6'-Dimethylacetamide 399.52 240–245
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Figure 1. Computational probability of presence (Ра) or absence (Рi) of local anesthetic property in the series of dimethylacetamide 
derivatives
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substances from the group of tertiary amino acid-substitu-
ted derivatives are highly likely to have a local anesthetic 
effect: a probability of this effect for LKhT-4-00 deriva-
tive with N-acetyl-L-glutamic acid as anion was the lar-
gest among others in the series, with Pa being 0.801. The 
tertiary derivative LKhT-3-00 with L-glutamic acid resi-
due is somewhat inferior to the predicted activity, with Pa 
being 0.669. Among the quaternized systems, only LKhT-
12-02 had a local anesthetic property (Pa is 0.528). So the 
aforementioned derivatives with high anesthetic potency 
were selected for further investigation.
Since one of the important practical issues was to com-
pare the range of therapeutic effect of the compounds with 
that of their structural analogs and other reference drugs, 
acute toxicity of dimethylacetamide derivatives was stu-
died through subcutaneous administration to rodents. The 
results of the study are shown in Figure 2.
In all cases, the replacement of the hydrochloride anion 
in lidocaine structure with the amino acid residue redu-
ced the molecule toxic profile. At the same time, the DL50 
index of the compounds changed in the ascending order 
as follows: lidocaine (236±7 mg/kg), its tertiary derivati-
ves with N-acetyl-L-glutamic acids residue (LKhT-4-00 
– 297±8 mg/kg) and L-glutamic acids residue (LKhT-3-
00 – 303±14 mg/kg). Different data on acute toxicity was 
obtained for the quaternary derivative LKhT-12-02 when 
administered subcutaneously. The DL50 index of the com-
pound was 118±4 mg/kg. In general, all studied compounds 
belonged to class 3 (moderately toxic) of substances toxi-
city and danger when administered subcutaneously.
The local anesthetic activity of the most promising 
tertiary and quaternary derivatives of dimethylacetamide 
on the terminal anesthesia model was studied at 0.5, 1.0, 
and 2.0% solution concentrations. The latent period of the 
anesthesia onset and its duration were determined. Reg-
nier index and EC30 were calculated. Simultaneously, a 
local irritant effect of the substances was recorded. Both 
of the investigated tertiary compounds are significantly 
inferior in strength and duration of activity to tetracaine 
at all studied concentrations. However, when comparing 
with a structural analogue, it was found that LKhT-3-00 
and LKhT-4-00 exceeded lidocaine in local painkilling 
action. Thus, with a similar latent period of anesthesia on-
set, Regnier index values of lidocaine at 2.0 – 1.0 – 0.5% 
concentrations were 315 – 149 – 53, the index values of 
LKhT-3-00 at the same concentrations were 456 – 234 – 
85, and index values of substance LKhT-4-00 were 514 – 
304 – 107. Such Regnier index values made it possible to 
suggest that the tertiary derivatives of dimethylacetamide 
caused deeper terminal anesthesia. The duration of the ef-
fect of the compounds also differed from that of lidocai-
ne. LKhT-4-00 exceeded lidocaine at all concentrations, 
whilst the substance under the laboratory code LKhT-3-
00 induced more continuous anesthesia only at the top 2% 
concentration. EC30 values of LKhT-3-00 and LKhT-4-00 
compounds were 1.78 and 1.47, respectively. 
The pharmacological characteristics of the effect of the 
quaternary derivative of LKhT-12-02 on this model were 
somewhat different. Being compared with all the referen-
ce drugs and tertiary compounds of lidocaine, the latent 
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Figure 2. Index values (Mean) of dimethylacetamide derivatives DL50 (DL100 for IV administration) for different administration 
routs (mg/kg). Note: IV – intravenous, IG – intragastric, SC – subcutaneous
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period of anesthesia onset induced by LKhT-12-02 sig-
nificantly increased: when the solution was instilled at a 
concentration of 0.5%, it averaged 17 minutes. The anal-
gesic effect developed at the fastest rate, within 13 min 
after instillation when the substance was administered at a 
maximum 2% concentration. The depth of anesthesia was 
also incomparably low in comparison with that reachd 
when administering the reference drugs. The obtained 
data were not enough to calculate the value of EC30 index, 
only with a certain approximation its value was possible 
to estimate at the level of 11.56.
Based on the results of the terminal anesthesia model 
of rabbit eye cornea and the data on acute toxicity of the 
compounds administered subcutaneously, the range of the 
compounds’ therapeutic effect was calculated. The results 
of the calculations are shown in Figure 3.
The lowest value of the index was estimated for the 
quaternary derivative of dimethylacetamide LKhT-12-02, 
which was due to a rather high toxicity and low pharmaco-
logical activity of the compound. From the authors’ point 
of view, the tertiary derivatives of lidocaine –LKhT-4-00 
and LKhT-3-00 compounds – had an optimal range of safe 
concentrations, which made it possible to consider them 
as potential drugs for applying in this type of anesthesia.
To assess the pharmacological activity of dimethy-
lacetamide derivatives on the infiltration anesthesia 
model, the Bulbring and Wajda method was used. Each 
compound was evaluated at three concentrations: 0.25, 
0.5, and 1.0%. The indices of infiltration anesthesia and 
relative local anesthetic activity were assessed (Fig. 4). 
The tertiary derivatives of dimethylacetamide exhibited 
local anesthetic properties on this model. LKhT-3-00 and 
LKhT-4-00 compounds at higher concentrations caused 
complete anesthesia.
In this case, the local anesthetic activity of LKhT-3-00 
substance at 1.0% concentration was inferior to that of li-
docaine, whereas the derivative with N-acetyl-L-glutamic 
acid as an anion (LKhT-4-00) was superior to the referen-
ce drug by the depth of anesthesia at 0.5% concentration. 
The quaternary compound LKhT-12-02 on this anesthesia 
model demonstrated no discernible pharmacological acti-
vity. The studied dynamics of the relative local anesthetic 
activity of lidocaine and of the compounds under study 
was dose-dependent: the depth of anesthesia increased 
with increasing concentration of the administered soluti-
on. However, it should be emphasized that lidocaine cur-
ve was more linear, while the derivatives’ curves had an 
exponential form, which indicated that these substances 
reached the threshold concentration at 0.4-0.6% level.
LKhT-3-00 and LKhT-4-00 demonstrated a high activi-
ty on the models of conduction anesthesia of mice tail and 
rat sciatic nerve. In the most concentrated solutions, the 
substances caused nerve conduction blockade compara-
ble in depth with reference drug bupivacaine hydrochlori-
de. The duration of the compounds’ effect when compared 
to that of lidocaine was significantly higher. The quater-
nary derivative LKhT-12-02 showed encouraging results 
on these models. After administering the compound, upon 
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Figure 3. Range of therapeutic doses index for dimethylacetamide derivatives calculated on rabbit cornea anesthesia model
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Figure 4. Curves of the derivatives’ relative local anesthetic action calculated on the model of infiltration anesthesia
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a latent period of 18 to 26 minutes, a deep and prolonged 
blockade followed, comparable with that after adminis-
tering bupivacaine. Moreover, the duration of the phar-
macological effect was 180 minutes. Figure 5 shows the 
ratios of the EC50 values calculated for the substances on 
models of conduction anesthesia in mice and rats.
From the data presented, it was clearly seen that EC50 
values for LKhT-3-00 and LKhT-4-00, as well as for 
LKhT-12-02 substance, obtained on different models of 
conduction anesthesia were very close to each other. At 
the same time, the most active compound on these models 
was derivative LKhT-12-02, despite the long latent period 
of the anesthesia onset.
In the experiments on isolated sciatic nerve specimens 
of the lake frog, the effect of dimethylacetamide derivati-
ves on action potential amplitude and A-fibers conduction 
was studied. The test substances suppressed both the to-
nic and rhythmic components of the conduction process. 
However, the relaxation time of volt-ampere profile of a 
nerve perfused by LKhT-12-02 was much slower and in 
contrast to lidocaine and its tertiary derivative LKhT-4-00 
lasted several hours (Fig. 6).
Thus, dimethylacetamide derivatives exhibited proper-
ties of local anesthetics effective for terminal, conduction 
and infiltration anesthesias.
Conclusions 
According to the obtained data, the following conclusions 
were made: 
1. Computer prediction of the presence of tertiary and 
quaternary (allyl and allylmorpholine) derivatives of 
dimethylacetamide in the therapeutic spectrum made 
it possible to select the compounds that were promi-
sing for further experimental studies: a compound with 
L-glutamic acid residue (LKhT-3-00, Pa 0.669), a com-
pound with N-acetyl-L-glutamic acid (LKhTT-4-00, 
Pa 0.801) and a quaternary derivative LKhT-12-02 (Pa 
0.528).
2. Acute toxicity of tertiary derivatives of dimethylace-
tamide LKhT-3-00 and LKhT-4-00 when administe-
red subcutaneously to mice was lower than that of the 
structural analog lidocaine, while the quaternary com-
pound was more toxic than lidocaine iwhen using this 
route of administration.
3. LKhT-3-00 and LKhT-4-00 had a local anesthetic acti-
vity on models of infiltration, terminal and conduction 
anesthesias, exceeding lidocaine in duration and depth 
of analgesic effect at 0.5-1% concentrations. LKhT-4-
00 compound had the widest range of therapeutic do-
ni
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Figure 6. Average washout time of (M±SD) the test substances at a concentration of 10 mМ when stimulating the isolated sciatic 
nerve
EC
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Figure 5. EC50 indices calculated for the derivatives on models of conduction anesthesia in mice and rats
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ses. The compounds did not cause a locally irritating 
effect on rabbit eye tissue.
4. N-allyl-N-(2,6-dimethylphenylaminocarbonylmethyl) 
morpholinium bromide (LKhT-12-02) compound had 
no analgesic effect on the models of terminal and infil-
tration anesthesias, but it induced a deep block of con-
duction over a mixed nerve lasting more than 3 hours. 
A specific pharmacological effect of the substance was 
a long latent period of an analgesic effect onset.
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Vétérinaire 133: 243–248. [in French]
  Riberio LNM, Breitkreitz MC, Guilherme V, da Silva GHR, Couto 
VM, Castro SR, de Paula BO, Machado D, de Paula E (2017) Natu-
ral lipids-based NLC containing lidocaine: from pre-formulation to 
in vivo studies. European Journal of Pharmaceutical Sciences 106: 
102–112. https://doi.org/10.1016/j.ejps.2017.05.060 [PubMed] 
  Sernov LN, Skachilova SYa, Druzhinina VV, Shilova EV, Blinov 
DS, Kostin YaV (2005) 2-diethylamino-2′,6′- dimethylphenylacet-
amide derivatives with antiarrhythmic activity. Journal of Chemistry 
and Pharmaceuticals [Khimiko-farmatsevticheskii zhurhal] 39(7): 
350–353. [In Russian] 
  Setnicar I (1966) Tolerance indices of some phenoxyethylamino de-
rivatives with local anaesthitic properties. Arzneimittel-Forschung 
16(5): 623. [PubMed]
Novikov AV et al.: On local anesthetic action of  some dimethylacetamide compounds8
Author contributions
  Andrei V. Novikov, postgraduate student, Faculty Surgery Department, National Research Ogarev Mordovia State 
University, 68 Bolshevistskaya St., Saransk, Russia 430005, elis2309@yandex.ru. The author conducted experi-
ments on animal models.
  Ekaterina V. Blinova, Doctor of Medical Sciences, Head of the Laboratory of Specific Pharmacological Activity, 
National Research Ogarev Mordovia State University, 68 Bolshevistskaya St., Saransk, Russia 430005; Professor 
of the Department of Operative Surgery and Clinical Anatomy, Sechenov University, 8/2 Trubetzkaya St., Moscow 
Russia 119991 bev-saransk@yandex.ru ORCID ID 0000-0003-0050-0251. The author organized the project.
  Elena V. Semeleva, Candidate of Medical Sciences, Associate Professor, Department of Public Health, National 
Research Ogarev Mordovia State University, 68 Bolshevistskaya St., Saransk, Russia 430005, shtanina37@mail.ru. 
The author conducted the statistic processing of the obtained data.
  Karina M. Karakhanjan, postgraduate student, Department of the Operative Surgery, Sechenov University, 8/2 
Trubetzkaya St., Moscow, Russia 119991, karinalion02@mail.ru. The author conducted the experiments on isola-
ted nerves and prepared the manuscript for publising.
  Mikhail A. Mironov, Assistant, the Department of the Hospital Surgery, National Research Ogarev Mordovia State 
University, 68 Bolshevistskaya St., Saransk, Russia 430005, doctorm@list.ru. The author conducted the experi-
ments on animal models.
  Dmirty S. Blinov, Doctor of Medical Sciences, Principal Researcher, Pharmacology Laboratory, All-Union Re-
search Center for Safety of Biological Active Substances, 23 Kirov St., Staraya Kupavna, Russia 125450, blin-
ov-pharm@yandex.ru ORCID ID 0000-0002-8385-4356. D.S. The author designed the project, provided consul-
ting support, and, finally, revised the manuscript.
  Yuliya S. Krainova, postgraduate student, Faculty Surgery Department, National Research Ogarev Mordovia State 
University, 68 Bolshevistskaya St., Saransk, Russia 430005, ksk_1991@rambler.ru The author conducted the ex-
periments on animal models.
  Dmitry V. Pakhomov, postgraduate student, Faculty Surgery Department, National Research Ogarev Mordovia 
State University, 68 Bolshevistskaya St., Saransk, Russia 430005, diman0910@mail.ru. The author conducted the 
experiments on animal models as well as did the statistic processing of obtained data.
  Olga V. Vasilkina, Candidate of Medical Sciences, Assistant Professor, Department of Hospital Surgery, National 
Research Ogarev Mordovia State University, 68 Bolshevistskaya St., Saransk, Russia 430005, ms.vasilkina@bk.ru. 
The author conducted the experiments on isolated nerves and prepared the manuscript for publishing.
  Elena A. Samishina, Candidate of Medical Sciences, Senior Researcher, Laboratory of Specific Pharmacological 
Aactivity, National Research Ogarev Mordovia State University, 68 Bolshevistskaya St., Saransk, Russia 430005, 
samy-elena@yandex.ru. The author conducted the experiments on animal models and prepared the manuscript for 
publishing.
